Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cochaperone
p23
plays an important role in estrogen receptor alpha (ER) signal transduction. In this study, we investigated how
p23
regulates ER target gene activation and affects tumor growth and progression. Remarkably, we found that changes in the expression of
p23
differentially affected the activation of ER target genes in a manner dependent upon the type of DNA regulatory element.
p23
overexpression enhanced the expression of the ER target genes
cathepsin D
and pS2, which are regulated by direct DNA binding of ER to estrogen response elements (ERE). In contrast, the expression of other target genes, including c-Myc, cyclin D1, and E2F1, to which ER is recruited indirectly through its interaction with other transcription factors remains unaffected by changes in
p23
levels. The
p23
-induced expression of pS2 is associated with enhanced recruitment of ER to the ERE in the promoter, whereas ER recruitment to the ERE-less c-Myc promoter does not respond to
p23
. Intriguingly,
p23
-overexpressing MCF-7 cells exhibit increased adhesion and invasion in the presence of fibronectin. Our findings demonstrate that
p23
differentially regulates ER target genes and is involved in the control of distinct cellular processes in breast tumor development, thus revealing novel functions of this cochaperone.
...
PMID:The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. 1680 59
Although cryosurgery is attaining increasing clinical acceptance, our understanding of the mechanisms of cryogenic cell destruction remains incomplete. While it is generally accepted that cryoinjured cells die by necrosis, the involvement of apoptosis was recently shown. Our studies of liver cell death by cryogenic temperature revealed the activation of endonuclease
p23
and its de novo association with the nuclear matrix. This finding is strongly suggestive of a programmed-type of cell death process. The presumed order underlying cryonecrotic cell death is addressed here by examining the mechanism of
p23
activation. To that end, nuclear proteins that were prepared from fresh liver, which is devoid of
p23
activity, were incubated with protein fractions isolated from liver exposed to freezing/thawing that possessed a presumed
p23
activation factor. We observed that the activation of
p23
was the result of a proteolytic event in which
cathepsin D
played a major role. Different patterns of proteolytic cleavage of nuclear proteins after in vitro incubation of nuclei and in samples isolated from frozen/thawed liver were observed. Although both processes induced
p23
activation, the incubation experiments generated proteolytic hallmarks of apoptosis, while freezing/thawing of whole liver resulted in typical necrotic PARP-1 cleavage products and intact lamin B. As an explanation we offer a hypothesis that after freezing, cells possess the potential to die through necrotic as well as apoptotic mechanisms, based on our finding that the cytosol of cells exposed to cryogenic temperatures contains both necrotic and apoptotic executors of cell death.
...
PMID:Proteolytic events in cryonecrotic cell death: Proteolytic activation of endonuclease P23. 2013 8